The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded an $8.74 billion indefinite delivery contract (IDC) to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, under the Joint Enterprise Research Development Acquisition and Production-Procurement (JE-RDAP) program. This multiple-award IDC, with a period of performance through November 2027, enables the agency to issue delivery orders for multiplex assay kits, components, and related services to support chemical and biological defense efforts. Meso Scale Diagnostics, a for-profit limited liability company, provides a range of products and services including assay development, laboratory testing equipment, immunoassays, and biomarker detection platforms. Recent task orders under this IDC have included $221,100 for Sector Model PR2 1800 instruments and a $1.8 million order for CBRNE defense systems, both on a firm fixed price basis. The agency has also utilized this IDC vehicle to issue a $1,000 delivery order for a contract start-up meeting.
In addition to this major IDC award, Meso Scale Diagnostics has received numerous federal grants and subcontract awards to support its research and development of biomarker detection technologies and assay capabilities. These include projects funded by the Defense Health Agency, National Institutes of Health, and other agencies to develop ultrasensitive immunoassays, flexible high-throughput assays for influenza vaccine studies, and innovations in extracellular vesicle characterization. Through its federal contracting and grant work, Meso Scale Diagnostics has supplied critical research tools and testing capabilities to support the missions of agencies such as the Department of Health and Human Services, Department of Homeland Security, and Environmental Protection Agency.
Generated 11/20/24, 9:05 AM